Discovery Laboratories (DSCO -1%) is outperforming the averages this morning after saying it's...

|By:, SA News Editor

Discovery Laboratories (DSCO -1%) is outperforming the averages this morning after saying it's responded to FDA quality control concerns regarding Surfaxin, its experimental preventative drug for respiratory distress syndrome in premature infants.